SAS Output

26-APR-2018 6:10

ERLYTX ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1609-Rare Tumor, Comb Nivo/Ipi 1 Y 1 Nivolumab + Ipilimumab 707 467 439 341 179 56 13 01/30/2017 340 158
            467 439 341 179 56 13      
 
Yes A071102-GBM, adj TMZ +/- Veliparib 0 E Total Registrations   126 16 16 10 3 1 02/02/2015 372 170
            126 16 16 10 3 1      
 
    1 E Total Registrations   40 3 3 2 1 0 02/02/2015    
            40 3 3 2 1 0      
 
  A071401-Prog Meningiomas,SMO/AKT/NF2 Inhib 0 E Total Registrations   35 8 3 1 0 0 02/22/2016 289 109
            35 8 3 1 0 0      
 
    1 E Total Registrations   5 0 0 0 0 0 02/22/2016    
            5 0 0 0 0 0      
 
  ARST1321-NonRhabdo STS,Pazopanib (PAZNTIS) 1 E Total Registrations   7 4 3 2 0 0 09/04/2015 251 117
            7 4 3 2 0 0      
 
  EAY131-MATCH 0 E Total Registrations   899 108 11 7 2 0 08/21/2015 464 235
            899 108 11 7 2 0      
 
    1 E Total Registrations   110 38 9 7 2 0 08/21/2015    
            110 38 9 7 2 0      
 
    2 E Total Registrations   8 4 1 0 0 0 08/21/2015    
            8 4 1 0 0 0      
 
    8 E Total Registrations   1 1 0 0 0 0 08/21/2015    
            1 1 0 0 0 0